Comparison of the ability of mammalian eEF1A1 and its oncogenic variant eEF1A2 to interact with actin and calmodulin

Area of Science:

• Molecular Biology
• Cellular Biology
• Oncology

Background:

• Oncoproteins interfere with cellular signaling pathways, but their specific structural and functional peculiarities are not fully understood.
• Tissue-specific isoforms of mammalian translation elongation factor eEF1A (A1 and A2) exhibit different oncogenic potentials, suggesting distinct molecular mechanisms.
• Understanding protein-isoform-specific interactions is crucial for elucidating oncogenic properties.

Purpose of the Study:

• To investigate the hypothesis that differential interactions with cellular partners contribute to the varying oncogenic potential of eEF1A isoforms A1 and A2.
• To compare the interaction capabilities of eEF1A A1 and A2 with calmodulin and actin.

Main Methods:

• In vitro binding assays to study the interaction of eEF1A isoforms A1 and A2 with calmodulin.
• Assessment of actin-bundling activity for both isoforms in the presence and absence of calmodulin.
• Analysis of the effect of calmodulin binding on eEF1A's tRNA-binding activity.

Main Results:

• The eEF1A A2 isoform demonstrated an inability to interact with calmodulin.
• Calmodulin successfully bound to the eEF1A A1 isoform.
• Calmodulin binding to eEF1A A1 interfered with its in vitro tRNA-binding and actin-bundling activities.
• Both A1 and A2 isoforms exhibited actin-bundling activity, but the resulting bundle structures differed significantly.
• A potential lack of Ca2+-mediated regulation for the A2 isoform was indicated.

Conclusions:

• Differential interaction with calmodulin is a key distinguishing feature between eEF1A A1 and A2 isoforms.
• The inability of A2 to bind calmodulin may underlie its distinct oncogenic potential and altered cellular regulation.
• These findings highlight the importance of isoform-specific protein interactions in cancer biology.